AMED

Amedisys Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

AMED price

Amedisys

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AMED

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AMED

Valuation

P/E

0.00

Sector 1.09

Industry -1.78

P/BV

0.00

Sector 1.86

Industry 1.35

P/Revenue (PSR)

Sector 1.55

Industry 2.25

EV/EBITDA

-0.15

Sector -47.62

Industry -42.38

EV/EBIT

-0.20

Sector -27.52

Industry -45.58

P/EBITDA

Sector -32.64

Industry -23.10

P/EBIT

Sector -43.02

Industry -27.18

P/Total Assets

Sector 0.87

Industry 0.82

P/Net Current Assets

0.00

Sector -27.09

Industry -72.46

P/Working Capital

0.00

Sector -4.05

Industry -2.10

EPS

2.93

Sector -0.70

Industry -1.11

BVPS

38.63

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

43.54%

Sector 49.36%

Industry 50.48%

EBITDA Margin

11.29%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

8.80%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

10.33%

Sector -19.73%

Industry -25.75%

Net Profit Margins

3.97%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.28

Sector 0.13

Industry 0.06

Profitability

ROE

7.59%

Sector -24.32%

Industry -33.33%

ROA

4.37%

Sector -24.41%

Industry -45.72%

ROIC

10.16%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.36

Sector 1.90

Industry 2.51

Net Debt / EBITDA

-0.15

Sector -4.96

Industry -8.98

Net Debt / EBIT

-0.20

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.01

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.26

Sector -0.74

Industry -0.56

Equity/Assets

0.58

Sector 0.46

Industry 0.52

Liabilities/Assets

0.42

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

1.78%

Sector -

Industry -

5Y Earnings CAGR

-13.87%

Sector -

Industry -

Fundamentals AMED

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Amedisys ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$50.46

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AMED Amedisys Inc.	$0.00	-	0.00%	0.00	0.00	7.59%	3.97%
HCA HCA Healthcare Inc.	$427.71	7.02%	0.70%	12.06	-29.52	-244.72%	10.07%
FMS Fresenius Medical Care AG & Co.	$22.20	-9.77%	2.77%	10.85	0.76	7.01%	4.84%
HUM Humana Inc.	$386.22	55.41%	0.93%	35.53	2.39	6.72%	0.89%
DVA DaVita Inc.	$183.86	41.26%	0.00%	9.90	-24.44	-246.80%	8.49%
WTW Weight Watchers International, Inc	$309.98	-6.50%	1.22%	18.44	3.74	20.26%	15.58%
LH Laboratory Corporation of America Holdings	$320.71	16.85%	0.90%	26.19	3.05	11.64%	6.99%
ALHC Alignment Healthcare Inc.	$8.35	-49.52%	0.00%	43.76	6.72	15.35%	0.89%
SGRY Surgery Partners Inc.	$13.25	-38.71%	0.00%	20.73	0.55	2.64%	2.43%
APR Apria Inc.	$0.00	-	0.00%	22.62	36.06	159.41%	5.53%
LLY Eli Lilly and Compay	$1,152.93	54.29%	0.59%	38.16	30.09	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$393.33	-10.35%	0.00%	44.01	7.60	17.26%	28.62%
SNY Sanofi	$42.48	-7.32%	4.17%	3.97	0.73	18.43%	14.25%
NVS Novartis AG	$140.37	16.41%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$651.45	36.43%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.61	-22.85%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.13	0.84%	3.11%	22.28	2.31	10.35%	14.02%
GSK GlaxoSmithKline PLC	$50.22	29.16%	3.54%	15.39	4.35	28.24%	14.54%
BSX Boston Scientific Corp.	$43.34	-55.70%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$86.42	-29.33%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$224.99	-16.77%	0.80%	21.51	4.98	23.13%	26.94%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AMED Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Amedisys

Amedisys Inc.

Average Investor10 user rating

4.0 (1 people)

United States

44 years

Founded: 1982

1994

Time since IPO - 32 years

21.000

Employees

Amedisys Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $1.27 billion.

The company employs approximately 21.000 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Amedisys Inc. reported $2.44 billion in revenue, generating net income of $96.79 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AMED.

Market cap

Net worth

$1.27 billion

$1,274,900,000.00

Assets

$2.22 billion

$2,215,390,000.00

Total Shares Outstanding

33.00 million

33,000,000

Average Daily Trading Volume

$571.97 Thousand

$571,965.48

Sector

Health

Industry

Health Services and Providers

AMED

AMED revenue and profits

Financial Results AMED

DRAG THE FRAME TO SEE MORE DATA

AMED cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.84 22,33% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.28 --3,05% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.11 104,94% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$386.22 55,41% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.48 --7,32% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,152.93 54,29% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$427.71 7,02% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$140.37 16,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35

CVS - CVS Health

$88.84 22,33% (12 M)

P/L

-0.79

3.01%

ROE

-178.93%

P/VP

1.42

CI - Cigna

$275.28 --3,05% (12 M)

P/L

10.57

1.69%

ROE

16.04%

P/VP

1.70

CNC - Centene

$65.11 104,94% (12 M)

P/L

-6.38

0.00%

ROE

-22.56%

P/VP

1.44

HUM - Humana

$386.22 55,41% (12 M)

P/L

35.53

0.93%

ROE

6.72%

P/VP

2.39

SNY - Sanofi

$42.48 --7,32% (12 M)

P/L

3.97

4.17%

ROE

18.43%

P/VP

0.73

LLY - Eli Lilly

$1,152.93 54,29% (12 M)

P/L

38.16

0.59%

ROE

78.84%

P/VP

30.09

HCA - HCA Healthcare

$427.71 7,02% (12 M)

P/L

12.06

0.70%

ROE

-244.72%

P/VP

-29.52

NVS - Novartis

$140.37 16,41% (12 M)

P/L

20.89

2.22%

ROE

30.39%

P/VP

6.35

Frequently Asked Questions

What is the price of Amedisys (AMED) today?

A cotação de Amedisys (AMED) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Amedisys (AMED) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Amedisys (AMED) e dados de ações do Ibovespa e mercados internacionais.

Quando Amedisys (AMED) paga dividendos?

Amedisys (AMED) não distribuiu dividendos no último ano.

Is Amedisys (AMED) a good investment?

Atualmente, Amedisys (AMED) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de 644% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Amedisys (AMED) stock?

Investir em ações de Amedisys (AMED) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Amedisys (AMED) yield today?

A rentabilidade de Amedisys (AMED) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Amedisys (AMED) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AMED

Amedisys Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AMED

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING AMED WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Amedisys

Amedisys Inc.

United States

44 years

1994

21.000

PROFIT X PRICE AMED

Financial Results AMED

AMED cash flow

Asset, Revenue and Profit Growth - AMED

AMED balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions